Carlo Incerti - Mar 2, 2022 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Stock symbol
DYN
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 05:23 PM
Next filing
May 25, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +39.2K $0.00 39.2K Mar 2, 2022 Common Stock 39.2K $8.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 2, 2022. The shares underlying the option are scheduled to vest over three years in equal monthly installments through March 2, 2025.